Last reviewed · How we verify
Propofol Fresenius plus lidocaine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Propofol Fresenius plus lidocaine (Propofol Fresenius plus lidocaine) — Hopital Foch.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Propofol Fresenius plus lidocaine TARGET | Propofol Fresenius plus lidocaine | Hopital Foch | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Propofol Fresenius plus lidocaine CI watch — RSS
- Propofol Fresenius plus lidocaine CI watch — Atom
- Propofol Fresenius plus lidocaine CI watch — JSON
- Propofol Fresenius plus lidocaine alone — RSS
Cite this brief
Drug Landscape (2026). Propofol Fresenius plus lidocaine — Competitive Intelligence Brief. https://druglandscape.com/ci/propofol-fresenius-plus-lidocaine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab